Phio Pharmaceuticals CORP S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
S-1: Phio Pharmaceuticals Files for Resale of Up to 5.9 Million Common Shares Following Recent Financings
Phio Pharmaceuticals is registering for resale up to 5.9 million shares of common stock, primarily related to warrants issued in recent private placements.
NASDAQ
Phio Pharmaceuticals has filed a registration statement for the resale of up to 1,131,468 shares of common stock by selling stockholders, primarily related to warrant exercises.
NASDAQ
Phio Pharmaceuticals aims to raise up to $100 million through a shelf registration, offering various securities to fund clinical development and corporate activities.